Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.

"following a similar logic for the asy group the npv is defined as npv = tn/(tn+fn) where tn and fn represent true and false negative respectively such that a high npv indicates that individuals predicted to be asy are truly asy s1 data relative breadth and average magnitudes of each kshv protein per sample are provided along with group averages."

"The authors have declared that no competing interests exist."

"This research was supported in part by the National Institute of Health grants from the National Cancer Institute R01 CA228178 (J.T.W. and C.W.), R01 CA239591 (C.W.), U54 CA221204 (C.W.), U54 CA190155 (C.W.), R01 DA047823 (C.W.), and K43 TW011418 (S.J.L.), Fogarty International D43 TW010354 (C.W.) and D43 TW012277 (C.W.), and Ruth L. Kirschstein National Research Service Award 1 T32 AI125207 (C.W.) from the National Institute of Allergy and Infectious Diseases. S.J.L. and O.N. were Fogarty fellows; and S.J.B. and S.R.P. were Ruth L. Kirschstein fellows. Finally, The University of Nebraska DNA Sequencing Core received support from the National Institute for General Medical Science INBRE (P20 GM103427-19) grant and The Fred & Pamela Buffett Cancer Center Support Grant (P30 CA036727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."